Hot Topic Sessions to Highlight DIA's 21st Annual Euromeeting The Drug Information Association's (DIA's) 21st Annual EuroMeeting will feature more than 125 sessions in 16 themes and 21 preconference tutorials focusing on issues affecting global drug discovery and development. (PRWeb Feb 18, 2009)
Read the full story at http://www.prweb.com/releases/2009/02/prweb2096544.htm
Source: www.prweb.comPatients Taking Cymbalta® Experienced Reduced Chronic Low Back Pain In New Study Data from a new study suggest that Cymbalta (duloxetine HCl) 60-120 mg once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) 24-hour average pain score, compared with placebo.(1) Results from the double-blind, 13-week, placebo-controlled study of 236 patients were presented today at the annual congress of the European Federation of Neurological Societies (EFNS) in Madrid, Spain.
Source: www.medicalnewstoday.comSingapore Leads Asia-Pac in Computer Aided Reconstructive Facial Surgery Singapore has taken the lead in medical innovation in the Asia-Pacific region with the introduction of a predictive computer system that virtually promises 100 percent accuracy in the difficult area of facial reconstruction surgery. (PRWeb Feb 18, 2009)
Read the full story at http://www.prweb.com/releases/singapore-medicine/asia-leading-medical-hub/prweb2082364.htm
Source: www.prweb.comEasing Back Pain Through Weights, Not Aerobics People who use weight training to ease their lower back pain are better off than those who choose other forms of exercise such as jogging, according to a University of Alberta study. The study, done in conjunction with the University of Regina, showed a 60 per cent improvement in pain and function levels for people with chronic backache who took part in a 16-week exercise program of resistance training using dumbbells, barbells and other load-bearing exercise equipment.
Source: www.medicalnewstoday.comBack Pain Still An Issue For Over 5 Million Australians: Are We Treating It Right? A new study by researchers at The George Institute for International Health has found that back pain is a reoccurring problem for five million Australians. According to lead author, Professor Chris Maher, Director of Musculoskeletal Research at The George Institute, "After an episode of back pain resolves, one in four people will experience a recurrence within one year. This explains why around 25% of the Australian population suffers from back pain at any one time.
Source: www.medicalnewstoday.comBiovail Receives Canadian Approval For Ralivia™ For The Treatment Of Moderately Severe Pain Biovail Corporation (NYSE:BVF)(TSX:BVF) announced that it has received an expanded indication for once-daily Ralivia™ - to include the treatment of moderately severe pain in addition to moderate pain - from the Therapeutic Products Directorate (TPD) in Canada. Ralivia™ is now indicated for the management of moderate to moderately severe pain in adults who require continuous treatment for several days or more.
Source: www.medicalnewstoday.comClues To Autism, Epilepsy, Mental Retardation From Rare Genetic Disorder A rare genetic disorder called tuberous sclerosis complex (TSC) is yielding insight into a possible cause of some neurodevelopmental disorders: structural abnormalities in neurons, or brain cells. Researchers in the F.M. Kirby Neurobiology Center at Children's Hospital Boston, led by Mustafa Sahin, MD, PhD, and Xi He, PhD, also found that normal neuronal structure can potentially be restored.
Source: www.medicalnewstoday.comBenefit Of Adipose-Derived Regenerative Cells In Spinal Disc Model Reported By Cytori Cytori Therapeutics, Inc. (NASDAQ: CYTX) reported preclinical study results, which demonstrate the potential benefit of adipose-derived stem and regenerative cells (ADRCs) for the treatment of damaged intervertebral discs, evidenced by significantly increased disc tissue density and disc-specific extracellular matrix components at 12-months post treatment in a large animal model. The data were presented at the 2008 Tissue Engineering and Regenerative Medicine International Society meeting.
Source: www.medicalnewstoday.comExperian QAS Delivers Address Validation Software Exclusive interview featuring Experian QAS' Joel Curry (PRWeb Feb 18, 2009)
Read the full story at http://www.prweb.com/releases/2009/02/prweb1965694.htm
Source: www.prweb.com
# posted by Network @ 12:25 PM
